Jim Gallagher

Article

Accelerating the establishment of precision medicine using PK-PD/TD modeling

Certara’s Japan team first met Dr. Kobuchi when he was studying Pharmacometrics at university for…

Jim Gallagher2021 年 11 月 18 日

Case Study

Dose Optimization Using Population PK for an Orphan Drug

RAPALIMUS® Tablets (sirolimus) is Nobelpharma’s orphan drug developed from an oral medication that is sold…

Jim Gallagher2021 年 11 月 17 日

Article

Leveraging real-world data to meet payers’ needs

Jim Gallagher2021 年 11 月 15 日

Article

Drug Discovery World：科学情报在药物发现中的价值

Jim Gallagher2021 年 11 月 9 日

Conference

PHUSE EU Connect

Jim Gallagher2021 年 11 月 9 日

Announcement

Certara Launches Fellowship Program in Africa for Applied Pharmacometrics Training

PRINCETON, N.J.— 2021 年 11 月 8 日 -- Certara, Inc, a global leader in biosimulation, today announced…

Jim Gallagher2021 年 11 月 8 日

Blog

开发靶向共价抑制剂药物：3关键考虑因素

Traditional mechanisms of drug action rely on the reversible, noncovalent interaction of a ligand with…

Jim Gallagher2021 年 11 月 5 日

White Paper

The Importance of Collecting Race/Ethnicity Information in Clinical Trials for Biologics – A Clinical Pharmacology Perspective

Jim Gallagher2021 年 11 月 2 日

Case Study

通过以数据为导向的科学方法，确定进入市场的路径战略

How Certara supported a gene therapy manufacturer by using a selection of gateway and value…

Jim Gallagher2021 年 10 月 28 日

Press Release

Certara Simcyp™ 新冠肺炎疫苗模型获R&D 100 奖

Biosimulation tool to conduct ‘what-if’ scenarios with virtual patients recognized in Software/Services category PRINCETON, NJ…

Jim Gallagher2021 年 10 月 25 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

Jim Gallagher

Accelerating the establishment of precision medicine using PK-PD/TD modeling

Dose Optimization Using Population PK for an Orphan Drug

Leveraging real-world data to meet payers’ needs

Drug Discovery World：科学情报在药物发现中的价值

PHUSE EU Connect

Certara Launches Fellowship Program in Africa for Applied Pharmacometrics Training

开发靶向共价抑制剂药物：3关键考虑因素

The Importance of Collecting Race/Ethnicity Information in Clinical Trials for Biologics – A Clinical Pharmacology Perspective

通过以数据为导向的科学方法，确定进入市场的路径战略

Certara Simcyp™ 新冠肺炎疫苗模型获R&D 100 奖

订阅时事通讯

快捷链接

解决方案

联系我们